Lactose (India) Faces Financial Challenges Amid Shift to Bearish Outlook

Lactose (India), a microcap company in the Pharmaceuticals & Biotechnology sector, has recently undergone an adjustment in its evaluation. This revision reflects a shift in the technical landscape, moving from a sideways trend to a mildly bearish outlook.
Key financial metrics indicate that Lactose (India) has faced challenges in its performance. The company reported a flat financial performance for the quarter ending June 2025, with a profit after tax (PAT) of Rs 2.36 crore, which represents a significant decline compared to previous periods. Additionally, the interest expense for the same period has shown growth, highlighting potential pressures on cash flow.

The company's ability to service its debt is also a concern, as evidenced by a high Debt to EBITDA ratio of 3.65 times. Furthermore, 26.07% of promoter shares are pledged, which can exert additional downward pressure on stock prices in a declining market.

Despite these challenges, Lactose (India) has demonstrated an attractive valuation with a return on capital employed (ROCE) of 9.72%. However, the stock has underperformed the broader market, with a return of -20.85% over the past year, compared to the BSE500's negative return of -7.50%.

Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.